GENEVA, Aug. 31 -- REPOS PHARMA AB filed a patent application (EP2026/054258) for “PRODRUGS OF BENZIMIDAZOLE DERIVATIVES OF FORMULA (I)”. With publication no. WO/2026/175846, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61P 29/00
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....